Age-related macular degeneration Trials in London, United Kingdom
Conditions / Age-related macular degeneration / London, United Kingdom
Age-related macular degeneration is a medical condition with active clinical research programs worldwide.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01944839 | A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy | TERMINATED | PHASE3 |
| NCT04005352 | Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) | COMPLETED | PHASE3 |
| NCT06682455 | Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2) | ENROLLING_BY_INVITATION | — |
| NCT03150589 | A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD) | COMPLETED | PHASE3 |
| NCT01016873 | INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD | COMPLETED | PHASE2 |
| NCT05230537 | A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00857259 | The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration | TERMINATED | PHASE2 |
| NCT00090532 | A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration | TERMINATED | PHASE1/PHASE2 |
| NCT05698316 | A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression | ACTIVE_NOT_RECRUITING | — |
| NCT01948830 | Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD | COMPLETED | PHASE3 |